1.

Introduction
Acute basilar artery occlusion (BAO) results in strokes characterized by poor outcomes and high mortality [1] . The most commonly applied therapies for acute BAO include intravenous and/or intraarterial administration of recombinant tissue plasminogen activator (IV rt-PA and IA rt-PA, respectively) and any-device mechanical thrombectomy (MT). There are few and rather small trials investigating therapeutic approaches in acute BAO, which is partially caused by the relatively low prevalence of this condition . Their results have been summarized and meta-analyzed in further studies [33] [34] [35] . These have suggested that mechanical thrombectomy, both in monotherapy or in combination with thrombolytic therapy, is the efficient therapeutic option in this type of stroke, whereas data for the effects of IV rt-PA and IA rt-PA are much less unequivocal [33] [34] [35] .
Only a few papers provide an analytical comparison of the selected two of the three basic methods of BAO treatment, and no one lists and statistically compares all three in one dissertation, as per a PubMed search [33] [34] [35] [36] . In this study, we performed meta-analyses of the basic common methods of the treatment of acute BAO in terms of the functional outcome, Fig. 1 -Funnel plots for (a) favorable outcome in group 2; (b) favorable outcome in group 3; (c) mortality in group 2; (d) mortality in group 3; (e) favorable outcome in groups 1 and 2; and (f) mortality in groups 1 and 2. 
and separately mortality, and compared the outcomes between each of the therapeutic approaches. We accommodated all BAO therapeutic trials published or being available on-line and/or in press by the end of January 2017. These included several recent articles that have never been taken into account in any of the previous meta-analyses. We divided and combined treatment protocols used in these studies into three groups: 1/lone IV rt-PA, 2/IA rt-PA preceded or not by IV rt-PA, and 3/any-device MT preceded or not by any route of rt-PA administration.
2.
Materials and methods 
Eligibility criteria
In the final analysis, we included observational or interventional studies, regardless of the project design, published in English, performed in an adult population, covering data about a minimum of 10 patients treated due to acute BAO, and reporting a 3-month assessment of the functional outcome by modified Rankin Scale (mRS) [37] . We excluded studies testing methods of the BAO treatment other than intravenous or intra-arterial thrombolysis with recombinant tissue plasminogen activator (rt-PA) and mechanical thrombectomy or their combinations. The main outcome measures included disability (mRS score 3 months after stroke onset) and mortality.
Treatment strategies and compared groups
We divided the selected BAO therapeutic trials and series' descriptions into three groups. The first included all studies testing the efficacy of intravenous thrombolysis alone (group 1: Fig. 2 -PRISMA flow diagram representing search strategy for the systematic review [39] . 
IV rt-PA). The second group included studies where patients were treated with intra-arterial thrombolysis, either alone or in combination with intravenous thrombolysis in any IV/IA rt-PA dose proportion (group 2: IV rt-PA AE IA rt-PA). The third group included studies in which patients were treated with mechanical thrombectomy, regardless of the device used, preceded or not with administration of rt-PA either IV or IA regardless of the dose (group 3: MT AE IA rt-PA AE IV rt-PA).
Taking into account the small number of studies in group 1, we expanded our analysis by combining groups 1 and 2 into one, thus comparing effects of any rt-PA treatment (either IV or IA or combined) with thrombectomy.
Summary measures
The main endpoint of this study was a 3-month mRS score, independent of other measures of the treatment, like recanalization or reperfusion. The favorable outcome was defined as mRS score 0-2 (patients functionally independent).
We have also performed an extra meta-analysis for mortality (3-month survivors versus deaths). Percentages and 95% confidence intervals were estimated for each study, as was the overall effect.
Statistical analysis
To establish variance of individual studies, we applied the Freeman-Tukey double arcsine transformation. The metaanalysis was based on a random effects model, where we applied a combination of DerSimonian and Laird model with transformed proportions. Ultimately, overall effects were back-transformed. The 95% confidence intervals of the estimates were performed using the Wilson method with continuity correction. Heterogeneity was assessed using the I 2 statistic and Q test. Overall effects for a favorable outcome, as well as for mortality, were compared using the Q-test based on analysis of variance [38] . All analyses were performed using the meta package for R V3.2.3. The significance threshold was set at .05. The possibility of publication bias was evaluated by visual analysis of a funnel plot, the Begg and Mazumdar's rank correlation test, and the Egger's linear regression.
2.6.
Comparison between the three therapeutic approaches
We compared the functional outcome and mortality between each of the three therapeutic approaches (groups 1, 2, and 3) using Q test subgroup analysis, based on analysis of variance. For this purpose, we assumed that the set of meta-analyses for the selected end-points (functional outcome, mortality) will constitute a set of the subgroups. This approach is commonly used in the subgroups analysis, although it does have some important limitations [38] .
Results
Study characteristics
Application of the given criteria through the two databases resulted in identification of 308 records. Following elimination of duplicates (including different analyses -papers based on the same treated populations) and screening of the titles and abstracts, the list of articles shortened to 57 items. Full texts of the latter were carefully read by two independent authors, who finally selected 31 studies with 1358 subjects to be included in the review and meta-analyses (Fig. 2) . MT devices used in the selected studies included Solitaire, Trevo, Catch, Phenox, Angio jet Ultra, ReVive, Penumbra. Among the analyzed studies, nine were prospective singlecenter trials, fifteen were retrospective single-center trials, and the remaining six were retrospective multicenter studies. Characteristics of the included articles are shown in Tables 3-5. 3.2.
Functional outcome and mortality (Fig. 3 ).
The mortality rates (mRS 6 at 3 months) were 25.00% (95% CI 4.80-53.03%/I 2 = 88.7%, p = 0.0001) in group 1, 42.79% (95% CI Fig. 3. (Continued ) . (Fig. 3) . The Q-test subgroup analysis revealed the statistical superiority of the mechanical thrombectomy (MT AE IV rt-PA AE IA rt-PA: group 3) over IA rt-PA AE IV rt-PA (group 2) (mRS 0-2: p = 0.0003, mRS 6: p = 0.0010) and over any rt-PA administration (either IV rt-PA or IA rt-PA AE IV rt-PA: combined groups 1 + 2) (mRS 0-2: p = 0.0006, mRS 6: p = 0.0056) ( Table 1) . Current data on specific BAO treatment are insufficient to assess the superiority between MT (MT AE IV rt-PA AE IA rt-PA: group 3) and IV rt-PA (group 1) or between IA rt-PA AE IV rt-PA (group 2) and IV rt-PA (group 1) due to low number of reported patients in the latter (Table 1) .
The weighted pooled estimate of a favorable outcome (mRS 0-2) for the effects of any rt-PA treatment (IA and/or IV; combined groups 1 and 2) was 24.18% (95% CI 18.95-29.80%/ I 2 = 53%, p = 0.0156), whereas the mortality rate (mRS 6) was 39.09% (95% CI 30.50-48.01%/I 2 = 80%, p < 0.0001).
Publication bias across studies
We found no evidence of publication bias in the funnel plot, the Begg and Mazumdar's rank correlation test, and the Egger's Fig. 3 .
(Continued
linear regression analysis ( Table 2 ). The overall evaluation of the risk of bias across studies is presented in Fig. 1 . However, of note is that the number of studies in the first group (IV rt-PA) was insufficient to explore the bias across them.
Discussion
This is a first work showing meta-analyses for the functional outcome of all three basic methods of the treatment of BAO, followed by a comparison between these approaches.
The main end-point for the analysis was defined as mRS 0-2, and the secondary end-point was survival, both after 3 months, with no extra variables, such as Barthel's Index or Glasgow Outcome Scale, used in some studies.
Our systematic review revealed that current empirical and observational data on the effects of the three basic approaches of the treatment of acute BAO are insufficient to generate highclass evidence-based medicine guidelines. Among the records shortlisted for this meta-analysis, there was no single randomized clinical trial. Interestingly, manually the easiest and the most available IV rt-PA had the poorest empirical information, summing up to only 2 studies (when considering 2 0 1 7 ) 4 8 6 -4 9 6 mRS) [2, 3] or 3 (when considering mortality) [2] [3] [4] . The studies were both retrospective and prospective, with a relatively small number of patients in each group, which carries a risk of publication bias and might overestimate outcome effects.
Despite those preliminary limitations, this analysis carries useful information. The percentage of favorable-outcome patients after IV rt-PA was 32.57%, whereas following IA rt-PA (preceded or not by IV rt-PA), it was 22.56%. In a former meta-analysis by Lindsberg and Mattle [36] , application of thrombolysis, either intravenous or intra-arterial, had comparable results regarding good outcome (22% and 24%, respectively) and obviously differed to the numbers revealed in our meta-analysis, mainly due to fewer studies being taken into account and different methodological approaches.
These current data provide a higher class of evidence for the superiority of the use of endovascular mechanical devices. The mechanical thrombectomy with the use of any endovascular device, preceded or not by any rt-PA administration, is the most efficient therapeutic method for this condition if measured by functional outcome and mortality. In our metaanalysis, this approach was better than two others (separately or combined), reaching the highest pooled estimate of favorable outcome and the lowest mortality rate.
The Q-test subgroup analysis revealed that the mechanical thrombectomy in BAO preceded or not by rt-PA administration (group 3) is superior to IA rt-PA preceded or not by IV rt-PA (group 2) and to any rt-PA administration (either IV rt-PA or IA rt-PA: combined groups 1 + 2). However, this analytical method, although frequently used for similar comparisons, has some limitations and must be treated with caution [38] .
Previous systematic reviews [33] [34] [35] have also demonstrated lower rates of mortality and higher likelihood of favorable outcome in acute BAO when mechanical thrombectomy was applied.
There are several basic variables that might influence the results of the effect of each of the therapeutic approaches. For example, IV rt-PA, IA rt-PA, and MT might have different efficiencies in different time windows after stroke. However, the authors assessing full texts of the papers (eligibility step of the systematic review) did not find sufficient data regarding the time from stroke onset to therapeutic intervention to be able to take them into account in the meta-analyses. 
Another limitation of our approach is the division of the therapies into three groups only. The ''bridging therapy'' (application of IV rt-PA prior to IA rt-PA or any or both of the two prior to MT), and the MT device construction, might influence the outcome, which was intentionally ignored in this analysis to obtain more reliable (including larger groups) data for the statistical workout. Finally, there are a lot of other factors ignored in the analyzed studies that might influence outcome after stroke such as for example blood pressure values in the early phase [40] , brain and body temperatures [41] [42] [43] , or various metabolic conditions and genetic variants [44] .
In conclusion, the stent-retriever mechanical thrombectomy seems to be the most effective method of treatment of BAO, showing a good safety profile. The efficacy of intravenous thrombolytic therapy remains unclear among others due to the insufficient number of studies and high heterogeneity across studies. Randomized controlled trials or large high-class observational studies are required to deliver unbiased data about the treatment of patients with basilar artery occlusion. 
